The Effects of Caffeine on Exercise Physiology and Time-trial Performance in a Hot Environment

NCT ID: NCT07129200

Last Updated: 2025-08-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-22

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Maintaining a stable core temperature is vital for physiological function; yet, exercise in heat can be problematic, and there is risk of exertional heat-related illness (Flouris \& Schlader, 2015; Leyk et al., 2019; Périard et al., 2021; Tyler et al., 2016; Veltmeijer et al., 2015). While aerobic fitness improves heat tolerance (Alhadad et al., 2019), strategies like acclimation and pre-cooling also mitigate heat stress (Casadio et al., 2016; Lorenzo et al., 2010; Ross et al., 2013; Siegel et al., 2010). Caffeine, an ergogenic aid (Del Corso et al., 2011; John et al., 2024), is known to enhance performance via adenosine antagonism and increased catecholamines in normothermic environments (Fredholm et al., 1999; Graham \& Spriet, 1991). However, effects in heat are inconsistent (Ganio et al., 2009; Zhang et al., 2014), possibly due to caffeine reducing the ability to thermoregulate effectively. Therefore, the aim of this study is to investigate the effects of a moderate dose of caffeine (5 mg/kg) on thermoregulation during a 30-minute running time trial in 35°C heat.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Caffeine Thermoregulation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Caffeine

5 mg/kg dose of caffeine (in pill form)

Group Type EXPERIMENTAL

Hot environment

Intervention Type OTHER

Hot environment of 35 degrees Celsius

Thermoneutral environment

Intervention Type OTHER

Thermoneutral environment of 18 degrees Celsius

Placebo

5 mg/kg dose of placebo (maltodextrin - in pill form)

Group Type PLACEBO_COMPARATOR

Hot environment

Intervention Type OTHER

Hot environment of 35 degrees Celsius

Thermoneutral environment

Intervention Type OTHER

Thermoneutral environment of 18 degrees Celsius

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hot environment

Hot environment of 35 degrees Celsius

Intervention Type OTHER

Thermoneutral environment

Thermoneutral environment of 18 degrees Celsius

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy trained runners

Exclusion Criteria

\-
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

St. Mary's University, Twickenham

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mark Glaister

Role: CONTACT

+447957616552

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SMU_ETHICS_2024-25_1111

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Heat Acclimation in Females
NCT06551168 RECRUITING NA